PRODUCT TEMPERATURE EXCURSION ISSUE

This adverse event was reported 5143 times

These drugs are most commonly taken by patients reporting PRODUCT TEMPERATURE EXCURSION ISSUE:

# Drug Count
0 ADALIMUMAB 281
1 SECUKINUMAB 247
2 RISANKIZUMAB-RZAA 200
3 OFATUMUMAB 186
4 ABATACEPT 183
5 VEDOLIZUMAB 162
6 ONABOTULINUMTOXINA 161
7 INSULIN GLARGINE 139
8 TOCILIZUMAB 131
9 GUSELKUMAB 121
See all common drugs associated with PRODUCT TEMPERATURE EXCURSION ISSUE

PRODUCT TEMPERATURE EXCURSION ISSUE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AVACINCAPTAD PEGOL 16 0.0455
1 TISOTUMAB VEDOTIN 22 0.0227
2 CRIZANLIZUMAB 22 0.0157
3 ANDEXANET ALFA 10 0.0141
4 ROPEGINTERFERON ALFA-2B 21 0.0113
5 INFLIXIMAB-DYYB 34 0.0099
6 BRENTUXIMAB VEDOTIN 94 0.0090
7 TESTOSTERONE ENANTHATE 11 0.0067
8 ETEPLIRSEN 16 0.0066
9 TUBERCULIN PURIFIED PROTEIN DERIVATIVE 11 0.0058
See all drugs enriched for association with PRODUCT TEMPERATURE EXCURSION ISSUE

PRODUCT TEMPERATURE EXCURSION ISSUE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Selectin Blocker [EPC] 22 0.0157
1 Protease Activator [EPC] 2 0.0155
2 Endoglycosidase [EPC] 26 0.0140
3 Interleukin-5 Antagonist [EPC] 8 0.0116
4 Interferon alfa-2b [EPC] 21 0.0113
5 CD30-directed Immunoconjugate [EPC] 94 0.0090
6 Interleukin-17A Antagonist [EPC] 247 0.0066
7 Skin Test Antigen [EPC] 11 0.0058
8 Cannabinoid [EPC] 46 0.0057
9 Guanylate Cyclase-C Agonist [EPC] 10 0.0048
See all drug classes enriched for association with PRODUCT TEMPERATURE EXCURSION ISSUE